Pyridine-containing molecules are important heterocyclic frameworks in biologically active natural products. This study evaluated the antimicrobial (antibacterial, antifungal) and antioxidant activities of synthesized 2-aminopyridine derivatives, focusing on their action against Gram-negative and Gram-positive bacteria, yeasts, and their radical scavenging capacity.
Antimicrobial activity was assessed using the disk diffusion method on Muller-Hinton Agar for bacteria and Sabouraud Dextrose Agar for yeasts. Gentamicin (10 µg) and Amphotericin B (0.2 mg) served as positive controls. Minimum Inhibitory Concentrations (MIC) were determined via broth microdilution, and MBC/MIC ratios evaluated bactericidal/fungicidal effects. Antioxidant activity was assessed using DPPH and ABTS radical scavenging assays. BHA and BHT served as references (0.002–0.1 mg/mL).
Disk diffusion showed inhibition zones of derivatives were significantly smaller than controls. Among the six tested 2-aminopyridine derivatives (AP1 to AP6), the active compounds (AP3, AP4, AP6) showed activity only against Gram-positive bacteria and C. albicans; no Gram-negative activity was observed. AP6 showed the best antibacterial activity against S. aureus (11.33±0.33 mm). AP4 and AP6 showed the best antifungal activity against C. albicans strains (13.66±0.33 mm each). MBC/MIC values indicated bactericidal and fungicidal effects. For antioxidant activity, AP5 showed the best DPPH reduction (IC50 = 246.65±2.08 µg/mL), followed by AP3 (451.81±9.32 µg/mL). In ABTS assays, IC50 values followed AP3 < AP5 (20.36±3.28, 32.41±2.29 µg/mL, respectively). ABTS assays revealed higher antioxidant activity for AP3 and AP5 compared to DPPH.
The tested compounds demonstrated bactericidal activity against Gram-positive bacteria and fungicidal activity, and showed promising antioxidant potential, though IC50 values remained distant from standards.